Recent News

• 11.24.2025 - iBio to Participate in the 8th Annual Evercore Healthcare Conference
• 11.24.2025 - iBio to Participate in the 8th Annual Evercore Healthcare Conference
• 11.12.2025 - iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
• 11.12.2025 - iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
• 10.30.2025 - iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
• 10.23.2025 - iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Recent Filings

• 11.21.2025 - 8-K Current report
• 11.17.2025 - 10-Q/A Quarterly report [Sections 13 or 15(d)]
• 11.17.2025 - 8-K Current report
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 8-K Current report
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]